With respect to the innate immune system, studies have been conducted with distinct types of cancer to analyze the role of TIM-3 as a negative regulator of the function of T lymphocyte-mediated adaptive immunity and innate response when this molecule is expressed in macrophages and DC. Here, HAVCR2 is linked to cancer.